TrialEfficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Trial details
- Registry ID
- NCT00254202
- Phase
- Phase 3
Drug research
Iloperidone
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as FANAPT®; Fanapt®; VYV-683
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaNCT00254202 | Vanda Pharmaceuticals | Phase 3 | Completed | 2006-09-26Actual |
| Relapse Prevention Study in Patients With SchizophreniaNCT01291511 | Vanda Pharmaceuticals | Phase 3 | Completed | 2014-03Actual |
| Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderNCT04819776 | Vanda Pharmaceuticals | Phase 3 | Completed | 2022-09-07Actual |
Relapse Prevention Study in Patients With Schizophrenia
Trial details
- Registry ID
- NCT01291511
- Phase
- Phase 3
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Trial details
- Registry ID
- NCT04819776
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |